Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Scripps Research Institute presents myosin-2 ATPase activity inhibitors

Jan. 8, 2020

Phase II study begins for URO-902 in overactive bladder

Dec. 24, 2019

Phase I study of Metablok achieves primary endpoints

Dec. 19, 2019

DiaMedica initiates phase II study of DM-199 in chronic kidney disease

Dec. 18, 2019

Alnylam presents topline data from ILLUMINATE-A phase III study of lumasiran

Dec. 18, 2019

FDA removes partial clinical hold for multiple-ascending-dose study of RGLS-4326

Dec. 17, 2019

Aurinia reports data from pivotal study of voclosporin in lupus nephritis

Dec. 5, 2019

New macrophage metalloelastase inhibitors discovered at Foresee Pharmaceuticals

Dec. 4, 2019

AstraZeneca identifies new TRPC3 and TRPC6 antagonists

Nov. 28, 2019

Peroxiredoxin-1 as a novel therapeutic target in LPS-induced AKI

Nov. 28, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...